Delivery Order SPE2DB24D1104-SPE2DB24FYCP0
Award Date
9/6/24
Potential Completion Date
9/27/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NUBEQA (darolutamide) 300 mg tablets. The $4,683.97 firm fixed-price contract has an ultimate completion date of October 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a wide range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,641.98 firm fixed-price delivery order is for the supply of 120 tablets of the medication Nubeqa 300 mg. The contract has a completion date of June 5, 2025 and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical supplier, for the delivery of NUBEQA 300 MG Tablets. The $4,683.97 firm fixed price contract has a ceiling value and an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. As a key supplier of medical commodities to the U.S. federal government, Amerisourcebergen leverages its extensive distribution network to provide a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a firm fixed price contract type and a ceiling value of $4,845.85. The order is for 120 tablets of the medication NUBEQA 300 MG, which is used to treat prostate cancer. The ultimate completion date for this order is December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,641.98 firm fixed-price delivery order is for the supply of 120 tablets of the medication NUBEQA 300 MG. The contract has an ultimate completion date of July 14, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division. The contract, valued at $9,367.94, is for the supply of 120 tablets of the pharmaceutical product NUBEQA 300 MG. The contract has a firm fixed-price pricing type and an ultimate completion date of October 3, 2024. The award was made on September 12, 2024, and there is no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds...
This is a $4,683.97 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of 120 tablets of the drug NUBEQA (300 mg). The contract has a completion date of September 4, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and $750,000...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 120 tablets of the medication NUBEQA 300 MG, with a ceiling value of $7,641.98 and a completion date of June 27, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,071,825 units of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The delivery order, valued at $3,518.40, has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $7,036.80 firm fixed-price contract is for the delivery of the drug Nubeqa 300 mg tablets. The contract has an ultimate completion date of January 12, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...